A new study estimates that thousands of lives could have been saved during the first year of the COVID-19 pandemic if convalescent plasma had been used more broadly, particularly in outpatients at ...

Findings from a nationwide, multicenter study led by Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health suggest that patients with COVID-19 have less chance of developing ...

Findings from a nationwide, multicenter study led by Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health suggest that patients with COVID-19 have less chance of developing ...

In a recent study posted to the medRxiv preprint server, researchers report that convalescent plasma treatment is most effective in treating hospitalized coronavirus disease 2019 (COVID-19) patients ...

A new study led by researchers at Johns Hopkins Bloomberg School of Public Health estimates that thousands of lives could have been saved during the first year of the COVID-19 pandemic if convalescent ...

A new analysis shows how convalescent plasma can be used to prevent hospitalizations and ultimately save lives, both for COVID-19 and for the next viral pandemic that inevitably arrives. Three years ...

Convalescent plasma, widely given to severely ill patients hospitalized with COVID-19 during the pandemic, does not improve their ability to survive or recover, according to a national clinical trial ...

Recently, humanity again confronted two new viral outbreaks, in the form of a hantavirus outbreak on a cruise ship and the resurgence of Ebola in Africa. There are no vaccines or antiviral drugs for ...

A new study led by researchers at Johns Hopkins Bloomberg School of Public Health estimates that thousands of lives could have been saved during the first year of the COVID-19 pandemic if convalescent ...

Three years into the COVID-19 pandemic, new variant outbreaks continue to fuel economic disruptions and hospitalizations across the globe. Effective therapies remain unavailable in much of the world, ...